Laboratory of Neuropharmacology, EAC CNRS 5006, University of Lyon 1, Lyon, France; PET Department, CERMEP-Imagerie du Vivant, 69003 Lyon, France.
Neuropharmacology. 2009 Dec;57(7-8):601-7. doi: 10.1016/j.neuropharm.2009.08.001. Epub 2009 Aug 13.
Attention-deficit/hyperactivity disorder (ADHD) is a neurobehavioral disorder characterized by inappropriate symptoms of inattention, impulsivity and motor restlessness. Converging data from neuropsychological, genetic, neurochemical and pharmacological studies have implicated fronto-striatal network abnormalities as the likely cause of ADHD. The functional imaging field has evolved rapidly providing unprecedented tools to examine questions regarding the pathophysiology of ADHD and the biological effects of medications used to treat it. Positron emission tomography (PET) provides unique quantitative information on the spatial resolution of radiolabelled molecules in the brain of patients or healthy subjects allowing the longitudinal assessment of physiological parameters such as binding potential over extended periods of time. The main goal of this review is to provide an overview of PET studies performed in ADHD patients, discuss their relative strengths and weaknesses and show how they can complement one another to enable a better understanding of the neurobiology and the neuropharmacology of this disease.
注意缺陷多动障碍(ADHD)是一种神经行为障碍,其特征为注意力不集中、冲动和运动不安等不适当的症状。神经心理学、遗传学、神经化学和药理学研究的综合数据表明,额纹状体网络异常可能是 ADHD 的原因。功能成像领域发展迅速,为研究 ADHD 的病理生理学以及用于治疗该病的药物的生物学效应提供了前所未有的工具。正电子发射断层扫描(PET)为患者或健康受试者大脑中放射性标记分子的空间分辨率提供了独特的定量信息,允许对生理参数(如结合潜力)进行长时间的纵向评估。本综述的主要目的是概述在 ADHD 患者中进行的 PET 研究,讨论它们的相对优缺点,并展示它们如何相互补充,以更好地了解这种疾病的神经生物学和神经药理学。